*One enrolled participant was later found to not meet eligibility criteria and was subsequently discontinued from product use, one enrolled participant was erroneously thought to not meet eligibility
Additional file 5. Supplementary Tables 1-12. (S1) Inclusion reason in the high-risk cohort, (S2) Cohort characteristics in breast cancer, healthy volunteers and high-risk cohorts, (S3) Discomfort of
The objectives of this study are to evaluate the utility of two gastrointestinal (GI) symptom scales (Individual GI Symptom and Impact Scale {IGISIS} and Global GI Symptom and Impact Scale {GGISIS})
AbstractIntroduction:Mycophenolate mofetil (MMF), pro-drug mycophenolic acid (MPA) is an immunosuppressive effective in the prophylaxis of acute rejection, but associated with gastrointestinal advers
Additional file 2. Complete blood count of dogs treated with 5-FC (100mg/kg, twice daily) at days 0, 1 and 7. No significant anomalies were noted. Bold numbers refer to values outside the reference in
